Your browser doesn't support javascript.
loading
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors.
Isakoff, S J; Tabernero, J; Molife, L R; Soria, J-C; Cervantes, A; Vogelzang, N J; Patel, M R; Hussain, M; Baron, A; Argilés, G; Conkling, P R; Sampath, D; Maslyar, D; Patel, P; Chan, W; Gendreau, S; Musib, L; Xu, N; Ma, H; Lin, K; Bendell, J.
Afiliação
  • Isakoff SJ; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, USA. Electronic address: sisakoff@partners.org.
  • Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Molife LR; Drug Development Unit, The Royal Marsden and Institute of Cancer Research, Sutton, UK.
  • Soria JC; Department of Cancer Medicine, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, and Université Paris-Sud, Orsay, France.
  • Cervantes A; CIBERONC, Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Vogelzang NJ; Division of Hematology/Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, USA.
  • Patel MR; Sarah Cannon Research Institute, Florida Cancer Specialists, Sarasota, USA.
  • Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA.
  • Baron A; Department of Medicine, California Pacific Medical Center, San Francisco, USA.
  • Argilés G; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Conkling PR; Virginia Oncology Associates, US Oncology Research, Norfolk, USA.
  • Sampath D; Genentech, Inc., South San Francisco, USA.
  • Maslyar D; Genentech, Inc., South San Francisco, USA.
  • Patel P; Genentech, Inc., South San Francisco, USA.
  • Chan W; Genentech, Inc., South San Francisco, USA.
  • Gendreau S; Genentech, Inc., South San Francisco, USA.
  • Musib L; Genentech, Inc., South San Francisco, USA.
  • Xu N; Genentech, Inc., South San Francisco, USA.
  • Ma H; Genentech, Inc., South San Francisco, USA.
  • Lin K; Genentech, Inc., South San Francisco, USA.
  • Bendell J; Drug Development Program, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, USA.
Ann Oncol ; 31(5): 626-633, 2020 05.
Article em En | MEDLINE | ID: mdl-32205017
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article